# Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)

> **NCT01052428** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 38 (actual)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DRUG:** metoprolol succinate (Toprol XL)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01052428
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2012-11-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052428, "Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01052428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*